Marketing-authorisation holder
Sanofi Medley Farmacêutica Ltda.
526 medicines in 1 country, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder
526 medicines in 1 country, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 526
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACICLOVIR | Aciclovir | Brazil | Authorised | 2015 |
| Acido Mefenamico | Mefenamic acid | Brazil | Authorised | 2015 |
| ADACEL | Pertussis toxoid, Hemaglutinina filamentosa, Toxóide diftérico, Aglutinógenos fimbriais bordetella pertussis dos sorotipos e, Toxóide tetânico, Pertactin | Brazil | Authorised | 2019 |
| adapaleno | Adapalene | Brazil | Authorised | 2015 |
| albendazol | Albendazole | Brazil | Authorised | 2015 |
| ALDURAZYME | Laronidase | Brazil | Authorised | 2019 |
| alopurinol | Allopurinol | Brazil | Authorised | 2015 |
| Alprazolam | Alprazolam | Brazil | Authorised | 2015 |
| amoxicilina + clavulanato de potássio | Amoxicillin, Clavulanic acid | Brazil | Authorised | 2025 |
| amoxicilina + clavulanato de potássio | Amoxicillin, Clavulanic acid | Brazil | Authorised | 2025 |
| APIDRA | Insulin glulisine | Brazil | Authorised | 2019 |
| apixabana | Apixaban | Brazil | Authorised | 2022 |
| ARAVA | Leflunomide | Brazil | Authorised | 2020 |
| ATENOLOL | Atenolol | Brazil | Authorised | 2015 |
| ATENOLOL + CLORTALIDONA | Atenolol, Chlorthalidone | Brazil | Authorised | 2015 |
| ATLANSIL | Amiodarone | Brazil | Authorised | 2020 |
| ATORVASTATINA CALCICA | Atorvastatin | Brazil | Authorised | 2015 |
| AUBAGIO | Teriflunomide | Brazil | Authorised | 2019 |
| AZITROMICINA DIIDRATADA | Azithromycin | Brazil | Authorised | 2015 |
| besilato de anlodipino | Anlodipino | Brazil | Authorised | 2015 |
| BEYFORTUS | Nirsevimab | Brazil | Authorised | 2023 |
| BIMATOPROSTA | Bimatoprost | Brazil | Authorised | 2015 |
| BISSULFATO DE CLOPIDOGREL | Clopidogrel | Brazil | Authorised | 2015 |
| BROMAZEPAM | Bromazepam | Brazil | Authorised | 2015 |
| BROMOPRIDA | Bromoprida | Brazil | Authorised | 2015 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 526 | 190 | 336 | CompaniesAll medicines |
Also in the registers of Singapore
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.